Benjamin T Diamond, Md

This study tests a new combination of four drugs (iberdomide, daratumumab, carfilzomib, and dexamethasone) in 30 people whose multiple myeloma has returned or stopped responding to prior treatments. The goal is to see if this combo can shrink the cancer and keep it from coming ba…